By Sue D’Arcy, Founder of iSMART Developments and faceLITE
Over the past year I’ve watched a wave of new LED face masks arrive on the market. Many of them make bold promises - “clinically proven wavelengths,” dramatic percentage improvements in wrinkles or elasticity, “precise doses,” superior coverage, and more. As someone who has spent more than 25 years developing and testing medical-grade LED devices, I feel a responsibility to help consumers understand the difference between marketing language and genuine clinical substantiation.
Here is a straightforward Q&A that explains the most common issues I see.
Q: What’s the biggest problem with many LED face-mask marketing claims?
A: They frequently present general photo biomodulation research, studies on other devices, or results from different wavelengths, doses and treatment protocols as if they prove the specific mask being sold. Consumers are left believing the product itself has been clinically demonstrated to deliver the advertised results, when the evidence is often extrapolated or incomplete. In addition, we have companies that are selling devices that are stated to treat spots and blemishes when really, they are treating mild to moderate inflammatory acne in order to avoid the onerous regulatory pathway that acne devices should adhere too.
Q: Why does device-specific evidence matter so much?
A: Wavelength alone is not enough. Irradiance, total energy (fluence), treatment distance, spectral accuracy, uniformity of light delivery, treatment duration and the exact combination of wavelengths all influence outcomes. A study performed on a different mask, a clinic panel, or a different dose schedule cannot automatically be applied to the product in the advertisement. Regulators rightly require robust evidence that matches the actual device, the doses consumers are instructed to use, and the precise claims being made. Unfortunately there is currently not a standardised method for measuring dose in LED’s, the only way to be sure of the results is to have specific clinical data.
Q: Are claims about “clinically proven wavelengths” or “precise, clinically proven doses” automatically valid?
A: No. Listing wavelengths that appear in the wider literature does not prove that the specific mask delivers those wavelengths at effective, uniform and correctly dosed levels under real-world use. Features that claim to deliver a “precise” or “personalised” dose need evidence that those exact combinations and doses have been tested on the product being sold. Evidence generated on an earlier model or on a completely different device is not sufficient.
Q: What about coverage claims or design features presented as superior?
A: These require clear definitions and supporting test data. How was “coverage” defined? Was measurement performed at the actual treatment distance? Was full spatial irradiance mapping conducted? Were comparators tested under identical conditions? A single-point measurement or loosely defined “detectable light” does not establish meaningful, uniform treatment-level illumination.
Q: What standard of evidence do regulators expect?
A: Evidence must relate to the actual product being advertised. Studies should preferably be controlled and large enough to support the claims. Results from other devices, different doses or different protocols are generally not accepted as primary substantiation. Specific efficacy claims need matching data and appropriate qualifications, so consumers are not misled.
Q: Are LED devices regulated?
A: For medical applications and claims such as acne, rosacea, psoriasis, pain and inflammatory conditions such as dermatitis and eczema; LED’s are regulated in the USA by the FDA and in Europe through the MDR process. Technical files including all the safety testing and clinical evaluations are performed to ensure safety and efficacy. Recently the MDR under the EU GMP Annex 16, now covers LED devices without a medical intended use that are used in professional settings. This means that any LED’s used in treatments in clinics, salons, spas and retail outlets need to be regulated in Europe and the UK.
Why faceLITE PRO is different
At iSMART Developments we have always taken a different approach. faceLITE is our own brand, designed and manufactured by the same team that has spent more than 25 years developing medical-grade LED technology and that continues to manufacture devices for many of the best-selling brands in the world. That depth of experience shapes everything we do.
The most important differentiator for any light therapy mask is not the number or exact positioning of individual LEDs. It is whether the device actually works and is supported by properly conducted clinical studies on the device itself. faceLITE PRO has both.
Our clinical studies (currently under peer review) demonstrate clear, measurablebenefits for wrinkles, reduction in under-eye dark circles, and improvement inpigmentation. The device was engineered with the scientific parameters of everywavelength carefully researched and validated, including 1070 nm.
We are the only company to have secured FDA clearance for the 1070 nm wavelength through a pathway that included clinical review specifically supporting its use for wrinkles, rather than relying on a generic product code. faceLITE PRO(model TN2508) is cleared under K260598 for the treatment of full-face wrinkles. There are currently no other face masks on the market with an FDA clearance that includes 1070 nm for this indication. We also have additional medical clearance spending that do not rely on the 510(k) route.
This builds on earlier work by members of the iSMART team previously obtained the first FDA de novo clearance for a 1070 nm device indicated for cold sores (herpes simplex labialis). The mechanistic research from that process is published and publicly available, and it underpins our understanding and application of this wave length today.
In short, faceLITE PRO has been properly researched and engineered. Thecombination of device-specific clinical evidence, the unique FDA pathway for 1070nm in wrinkle treatment, and the foundational scientific work on this wavelengthgives us strong confidence in its performance.
That is the standard I have insisted on throughout my career - evidence thatmatches the product consumers actually buy. Not louder marketing. Not broaderclaims drawn from other devices. Simply rigorous, transparent science applied to themask itself.
